PET

You have access
¹⁸F-Fluorocholine PET/CT as an Imaging Biomarker in Patients With Hepatocellular Carcinoma Receiving Atezolizumab Plus Bevacizumab
WONSEOK WHI, HYUNJONG LEE, JUNG YONG HONG, WONSEOK KANG, YOUNG SEOK CHO, SEUNG HWAN MOON, JOON YOUNG CHOI, KYUNG-HAN LEE and SEUNG HYUP HYUN

Anticancer Research March 2025, 45 (3) 1273-1280; DOI: https://doi.org/10.21873/anticanres.17514
Open Access
[¹¹C]Methionine PET vs. [¹⁸F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN

Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
You have access
Effect of Epidermal Growth Factor Receptor Mutation on Positron Emission Tomography/Computed Tomography in Lung Cancer
JI SUN PARK, HA YOUNG PARK and YUNSEON CHOI

Anticancer Research June 2024, 44 (6) 2681-2687; DOI: https://doi.org/10.21873/anticanres.17075
You have access
Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, NAO KITASAKI and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 6037-6045; DOI: https://doi.org/10.21873/anticanres.16115
You have access
Tumor-infiltrating Lymphocyte Score Based on FDG PET/CT for Predicting the Effect of Neoadjuvant Chemotherapy in Breast Cancer
SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, NORIO MASUMOTO, TAKAYUKI KADOYA, KOJI ARIHIRO and MORIHITO OKADA

Anticancer Research June 2020, 40 (6) 3395-3400; DOI: https://doi.org/10.21873/anticanres.14323
You have access
Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using ¹⁸F-FDG-PET/CT and ¹⁸F-NaF-PET/CT
THOMAS SELIM NAKUZ, FILIPE PORTELA MILLINGER, KAREM EL-RABADI, MICHAEL WEBER, VERENA PICHLER, WOLFGANG WADSAK, MARKUS MITTERHAUSER, ALEXANDER HAUG, MARCUS HACKER, GEORGIOS KARANIKAS, PETER PIETSCHMANN and HERMINE AGIS

Anticancer Research April 2019, 39 (4) 1943-1952; DOI: https://doi.org/10.21873/anticanres.13304
You have access
Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
TOMOHITO HAGI, TOMOKI NAKAMURA, YUICHI SUGINO, TAKAO MATSUBARA, KUNIHIRO ASANUMA and AKIHIRO SUDO

Anticancer Research June 2018, 38 (6) 3635-3639; DOI: https://doi.org/10.21873/anticanres.12638
You have access
Associations Between Histogram Analysis DCE MRI Parameters and Complex ¹⁸F-FDG-PET Values in Head and Neck Squamous Cell Carcinoma
ALEXEY SUROV, LEONARD LEIFELS, HANS JONAS MEYER, KARSTEN WINTER, OSAMA SABRI and SANDRA PURZ

Anticancer Research March 2018, 38 (3) 1637-1642;
You have access
Clinical Value of ¹⁸F-FDOPA PET/CT With Contrast Enhancement and Without Carbidopa Premedication in Patients with Insulinoma
THOMAS SELIM NAKUZ, ERIK BERGER, KAREM EL-RABADI, WOLFGANG WADSAK, ALEXANDER HAUG, MARCUS HACKER and GEORGIOS KARANIKAS

Anticancer Research January 2018, 38 (1) 353-358;
You have access
Differential Prognostic Value of Metabolic Heterogeneity of Primary Tumor and Metastatic Lymph Nodes in Patients with Pharyngeal Cancer
JEON YEOB JANG, KYOUNG JUNE PAK, KEUN-IK YI, YONG KAN KI, WON TAEK KIM, HYOJEONG KIM, YOUNG JIN CHOI, SEONG JANG KIM, IN JOO KIM, SOO-GEUN WANG and YOUNG MI SEOL

Anticancer Research October 2017, 37 (10) 5899-5905;

Main menu

User menu

Search

PET

Pages